Member Info for Woodlands

Exactly, if someone had keeled over after taking the tablets we would have heard by now and the trial would be in the bin, but we haven't and it isn't. Good luck to those trading a % of their pot. I'm not sure I've got the balls as soon as I sold 10% trying to make some beer money the RNS I've waited more than 10 years to arrive will drop. So I'll just sit tight for a few more weeks. Although RF and PH were a pair of tag team twunts who caused some stress and dilution they did give us all an opportunity to significantly increase our holding at silly prices.

TBF to TM he has left a fairly big hint on the front page of their website; “Sareum is making steady progress with the ongoing trial of SDC-1801 and the data we have seen so far support our confidence that it has the potential to deliver therapeutically effective dose levels with no serious adverse events”

Tim Mitchell PhD – Founder and CEO

The sp hit 9p in August 2021 we have had a 50:1 consolidation so £4.50 but we have also issued more shares so to achieve the same MCap as then we would see a sp of approximately £3.

I'm not sure about retirement but I might be tempted to upgrade the car later in the year. As a nod to Toth 28p *50 (consolidation) = £14 *0.67 (dilution) = £9.38. Now that would probably get more than just a nice car.

“Sareum is making steady progress with the ongoing trial of SDC-1801 and the data we have seen so far support our confidence that it has the potential to deliver therapeutically effective dose levels with no serious adverse events”

Tim Mitchell PhD – Founder and CEO **Credit to sixthavenue who spotted this on the Sareum website and posted it over the weekend. I thought it was worth re-posting for those who don't read the board at the weekend.

When did this appear on the website? I had a look midweek but didn't spot it. Tim is a fairly measured fella so this is very positive.

Boyasaka I take your point RE MCap and I posted my numbers as below to try and highlight this which included number if shares in issue then and now and £100million Mcap as a nice tound number. Maybe stop telling people off for their maths as some might say your English could be a little better.

I tend to agree with the sentiment of the 3 Bs and the tide has certainly turned, although Mayhem you are also spot on. I was trying to do the maths. A MCap of £100m pre RF would have been a sp of £1.47 but would now be more like 94p. I'm not sure if MathsProf or any closer to the numbers can confirm. Previously 68,000,000 shares now 107,000,000. I also suspect LTHs will have taken part in the Wrap/ topped up at 10.5p whilst they might sell some on the way up I think they are now in sticky hands, so this could get interesting especially once we get news from Melbourne.

You had plenty of bottle when you chucked 100 grand in at 9p / £4.50.

This looks like a good time for you to get your average down

Nicely, assuming you are genuine, might it be worth you buying a few shares at 30p to reduce your average / breakeven? I bought in years ago at 1.44p so 73p new money then when the Wrap was happening I topped up at 10.5p so 0.21p old money. I think this could be your solution.

Hi Trickey, I have been here for more years than I care to remember, originally buying at 1.44p which would be 73p in today's SP. The current SP is = to 0.5p pre-consolidation and in August 2022 the SP went above 9p which would be £4.50 in new money. So I would suggest that a 100% increase from the current SP will only be the start of the increase back to a more sensible MCap. I'm just hoping we see an RNS that says TM has told RF to FO. Full steam ahead.

That's a good spot.....🕵️

Hi Mitty, those numbers are remarkably similar to mine. I still intend to stay for the long game, I just hold more shares than I thought I would.

I can't say I completely understand the arrangement with RF, but having originally bought in at 1.4p in old money,70p in today's currency, and seen the SP drop down to 0.2p and also seen it race up to 9p in August 2021 which is £4.50 in new money I decided the opportunity to buy at these levels was too good to miss. I had two top ups yesterday morning and another this morning. After many. many years here we are now expecting data from the trial in Q2 2024 ie any time in the next 12 weeks and if that news is positive I'm not sure it will matter how many shares RF sell the SP will only be going in one direction.

That seems to make sense, I was just being a bity grumpy yesterday when Barclays couldn't facilitate. I've been a bit out of touch recently although it strikes me if Sareum can get shot of RF, followed by some positive data from Oz then we could be in for a much more positive second half of the year.

I tried to participate in the WRAP Retail offer yesterday but when I contacted Barclays they said that they weren't able to facilitate and I'm sure I read that someone had the same issue with Halifax. Instead I bought this morning on the open market at 10.3p but I appreciate that doesn't help Sareum in the manner intended by the WRAP. If Sareum are looking to raise funds in such a way in the future, and clearly there is an appetite amongst the retail investors to support this, would Sareum be able to get Barclays, Halifax et al engaged in the process? I'm assuming many of us hold Sareum in our ISAs with "high street" banks, so surely this would increase the amount they could raise via LTHs?

Agreed, I thought it was pretty clear, Plan A and probably Plan B is to complete 1B and then licence. Which as I recall has always been the plan. I remember from the previous presentation how important it is to get the clinical data which will then lead to a licence deal and at a bigger £number.

So lets call it £8.10 for 737 and whatever you think 1801 will be worth once we have the "clinical data", £14 seems like a nice number.... especially if you divide it by 50 :-)

Some great questions from the shareholders who attended, the 3 things I took away from it; 1 they are all incredibly confident and relaxed about the direction of travel and chance of success and were happy to share and reinforce this confidence including when discussing interest in 737 and what has been asked of them in terms of showing some clinical data for 1801 at which point a big pharma will rock up with a big bag of swag. 2 John Reader has clearly reached the end of his tether with MHRA and feels like they have d1cked him about hence going to a European regulator and 3 I have never seen or heard Tim be quite so upbeat, confident, animated and relaxed. This is a man who is cautious and conservative by nature and whilst very clever someone who never looks overly comfortable in the limelight, by contrast today he looked like he might put his feet up on the desk and light a big cigar. He has been working on this for many years and can see the finish line is in sight. There has been a delay caused by an under resourced bureaucratic regulator with their own agenda, nothing has changed with Sareum's products. We are currently at 1.3p in old money, and no speeding tickets were issued when we hit 9p.........